Quantcast

Latest Piperazines Stories

2014-08-08 08:26:35

First ADASUVE Launch in Latin America MOUNTAIN VIEW, Calif., Aug. 8, 2014 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced that ADASUVE(®) inhalation powder, pre-dispensed (loxapine) is now available in Guatemala. This approval represents the first ADASUVE approval in Latin America for Ferrer and Alexza. Ferrer is Alexza's commercial partner for ADASUVE in the EU, Latin America and Commonwealth of Independent States countries. Ferrer introduced ADASUVE during a...

2014-08-05 08:33:13

Peer-Reviewed Case Study from Fox Chase Cancer Center Demonstrates Value of Company's Unique Approach to Precision Medicine to Uncover Critical Treatment Insights IRVING, Texas, Aug. 5, 2014 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of precision medicine, announced today publication of a case study in which the company's comprehensive tumor profiling service, Caris Molecular Intelligence(TM), helped guide successful...

2014-07-30 12:30:25

PISCATAWAY, N.J., July 30, 2014 /PRNewswire/ -- InnoPharma, Inc. today announced the first generic launch of Olanzapine for Injection, 10mg/vial (the generic equivalent of Zyprexa® injection), in Canada. Olanzapine is indicated for the rapid control of agitation and disturbed behaviors in patients with schizophrenia or bipolar I mania. As the developer of this generic injectable drug, InnoPharma has entered into an agreement with Sandoz Canada Inc., pursuant to which Sandoz Canada...

2014-07-27 12:20:59

LifeScienceIndustryResearch.com adds Latest Report on "Global and Chinese Vardenafil (CAS 224785-90-4) Industry, 2009-2019 Market Research Report" to its store. DALLAS, July 27, 2014 /PRNewswire-iReach/ -- This is a professional and in-depth market survey on Global and Chinese Vardenafil (CAS 224785-90-4) industry. The report firstly reviews the basic information of Vardenafil (CAS 224785-90-4) including its classification, application and manufacturing technology. The report then...

2014-07-24 23:10:39

The DrugNews Center is the largest source for prescription drug and medical device warnings, research and legal news. Visit http://www.DrugNews.net today. Chicago, IL (PRWEB) July 24, 2014 The prescription drug safety center DrugNews.net has added new research information to the site for patients who have taken popular erectile dysfunction drugs like Viagra. Following a recent study that found men who’d taken the drugs had a higher rate of skin cancer*, a new report offers an...

2014-07-17 23:04:12

LifeScienceIndustryResearch.com adds latest report on “Global and Chinese Sildenafil Citrate (CAS 171599-83-0) Industry, 2009-2019 Market Research Report” to its store. Inquire before buying this report at http://www.lifescienceindustryresearch.com/inquire-before-buying?rname=15625. Dallas, TX (PRWEB) July 17, 2014 This is a professional and in-depth market survey on Global and Chinese Sildenafil Citrate (CAS 171599-83-0) industry. The report firstly reviews the basic information of...

2014-07-15 12:29:21

The Upcoming Entry of New Generation TKIs will Challenge the Established Position of CML Treatments in Brazil and Mexico, According to Findings from Decision Resources Group BURLINGTON, Mass., July 15, 2014 /PRNewswire/ -- Decision Resources Group finds that, despite the fact that the treatment armamentarium for chronic myeloid leukemia (CML) in Brazil and Mexico includes all three tyrosine kinase inhibitors (TKIs)--Novartis' Glivec (imatinib), Bristol-Myers Squibb's Sprycel (dasatinib) and...

2014-07-14 08:26:29

Submission based on first head-to-head study vs. oral treatments in real world context TITUSVILLE, N.J., July 14, 2014 /PRNewswire/ -- Janssen Pharmaceuticals, Inc. today announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) seeking a label change that, if approved, would include new data showing significantly delayed time to relapse in patients prescribed once-monthly atypical long-acting antipsychotic INVEGA(®)...

2014-07-09 08:27:55

WOODCLIFF LAKE, N.J., July 9, 2014 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for fluphenazine decanoate injection, USP 25 mg/mL. Fluphenazine decanoate injection is a long-acting parenteral antipsychotic drug intended for use in the management of patients requiring prolonged parenteral neuroleptic therapy (e.g., chronic schizophrenics)....

2014-07-08 23:00:27

The DrugNews Center is the largest source for prescription drug and medical device warnings, research and legal news. Visit http://www.DrugNews.net today. New York, NY (PRWEB) July 08, 2014 The prescription drug safety center DrugNews.net has added new research information to the site for patients who have taken popular erectile dysfunction drugs like Viagra. A recent European study shows a high percentage of erectile dysfunction drug use is not prescribed*. This follows another recent...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.